Mesothelin UCAR-T

N/A

Report date: 2025/03/20 15:34:19

Base Information

Drug NameMesothelin UCAR-T
Drug Alias Nameanti-mesothelin CAR T-cell therapy (Suzhou Maximum Bio-Tech)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionMesothelin modulators
TargetsMesothelin
Therapy Area/IndicationsGenital Diseases, FemaleUterine Cervical NeoplasmsOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesT-Maximum Pharmaceutical (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesT-Maximum Pharmaceutical (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsGenital Diseases, FemaleUterine Cervical NeoplasmsOvarian Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A